Good Life Advisors LLC lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 54.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,763 shares of the company's stock after selling 3,337 shares during the quarter. Good Life Advisors LLC's holdings in Cardinal Health were worth $327,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also made changes to their positions in CAH. Convergence Investment Partners LLC lifted its holdings in shares of Cardinal Health by 32.0% in the 4th quarter. Convergence Investment Partners LLC now owns 33,125 shares of the company's stock valued at $3,918,000 after acquiring an additional 8,023 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund lifted its stake in shares of Cardinal Health by 67.5% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 12,093 shares of the company's stock valued at $1,430,000 after purchasing an additional 4,873 shares during the last quarter. Kestra Investment Management LLC boosted its holdings in shares of Cardinal Health by 78.7% in the 4th quarter. Kestra Investment Management LLC now owns 3,264 shares of the company's stock worth $386,000 after purchasing an additional 1,437 shares during the period. Atria Wealth Solutions Inc. increased its position in shares of Cardinal Health by 20.9% during the 4th quarter. Atria Wealth Solutions Inc. now owns 56,992 shares of the company's stock valued at $6,740,000 after purchasing an additional 9,837 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its holdings in Cardinal Health by 86.0% during the 4th quarter. Venturi Wealth Management LLC now owns 1,812 shares of the company's stock valued at $214,000 after buying an additional 838 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
CAH has been the subject of several recent analyst reports. Citigroup lifted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research note on Friday, January 10th. UBS Group upped their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a report on Monday, November 4th. Morgan Stanley increased their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. increased their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus target price of $136.87.
Check Out Our Latest Stock Report on CAH
Cardinal Health Trading Down 0.3 %
Shares of Cardinal Health stock traded down $0.42 during trading on Friday, hitting $126.96. 2,354,573 shares of the stock traded hands, compared to its average volume of 2,342,976. The stock's fifty day simple moving average is $123.45 and its 200 day simple moving average is $116.88. The firm has a market cap of $30.67 billion, a P/E ratio of 23.69, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.59%. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
